Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FNMWX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,012
Award facts
- Contract value 100% obligated
- $26,011.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $26,011.96 by the Defense Logistics Agency on September 9, 2025, for the supply of Tecentriq 1,200 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, was issued without a set-aside designation. The award was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Tecentriq, an oncology treatment used in cancer therapy, represents one of many specialized pharmaceutical products that DMS Pharmaceutical Group supplies to the Department of Defense healthcare system. The company's positioning as a critical supplier in the federal pharmaceutical supply chain reflects its extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables delivered to military health facilities across the country. This delivery order supports the Defense Logistics Agency's mission to provide medical supplies and medications to federal healthcare systems and demonstrates the contractor's continued role in supplying essential pharmaceutical products to the defense establishment.
Quick answers
Who was awarded contract SPE2DB25FNMWX?
SPE2DB25FNMWX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FNMWX worth?
The government has obligated $26,012 on SPE2DB25FNMWX.
Is contract SPE2DB25FNMWX an order under another contract?
Yes. SPE2DB25FNMWX is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMWX competed?
The extent of competition for SPE2DB25FNMWX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award